| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Net loss attributable to common stockholders | -2,806 | -2,320 | ||
| Net loss per common share, basic and diluted (in dollars per share) | -0.19 | -0.15 | ||
| Weighted average common shares outstanding, basic and diluted (in shares) | 14,739,800 | 15,543,321 | ||
Allarity Therapeutics, Inc. (ALLR)
Allarity Therapeutics, Inc. (ALLR)